TeraImmune, Inc Email Format

BiotechnologyMaryland, United States11-50 Employees

TeraImmune, Inc. is a biotechnology research company based in Gaithersburg, Maryland, focused on developing immunotherapies rooted in regulatory T cells. Its work encompasses expanding human regulatory T cells in vitro and developing receptors that target pathological immune cells, including T cells, B cells, and antigen-presenting cells. The firm aims to convert this biology into therapies for autoimmune diseases, with TI-168 identified as its lead clinical-stage asset and ongoing efforts to establish scalable manufacturing for clinical use.

In 2023, TeraImmune extended its collaboration with the National Institute of Allergy and Infectious Diseases to continue developing regulatory T-cell–based therapies for multiple sclerosis and other autoimmune diseases. During the year, the company progressed the cGMP-compliant manufacturing protocol for its lead candidate TI-168 to support upcoming clinical trials.

Sign up for free to view info

Company overview Employee directory